Recurrent undifferentiated embryonal sarcoma of the liver in adult patient treated by pembrolizumab: A case report.

Yu, Xiao-He; Huang, Jian; Ge, Nai-Jian; Yang, Ye-Fa; Zhao, Jin-Yan

Yu, Xiao-He; Huang, Jian; Ge, Nai-Jian; Yang, Ye-Fa; Zhao, Jin-Yan.

Afiliación

Yu XH; Department of Radioactive Intervention, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai 200438, China.
Huang J; Department of Radioactive Intervention, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai 200438, China.
Ge NJ; Department of Radioactive Intervention, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai 200438, China.
Yang YF; Department of Radioactive Intervention, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai 200438, China.
Zhao JY; Department of Laboratory Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China. jingy1213@163.com.

World J Clin Cases ; 9(10): 2281-2288, 2021 Apr 06.

Article en En | MEDLINE | ID: mdl-33869604

Palabras clave

Case report; Immunohistology; Pembrolizumab; Programmed cell death protein 1; Tumor mutation burden; Undifferentiated embryonal sarcoma of the liver

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: World J Clin Cases Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google